Key points are not available for this paper at this time.
Background Fusobacterium nucleatum, a pathobiont in periodontal disease, contributes to alveolar bone destruction. We assessed the efficacy of a new targeted antimicrobial, FP-100, in eradicating F. nucleatum from the oral microbial community in vitro and in vivo and evaluated its effectiveness in reducing bone loss in a mouse periodontitis model.
Building similarity graph...
Analyzing shared references across papers
Loading...
Nil Yakar
Özge Ünlü
Lujia Cen
Journal of Oral Microbiology
Harvard University
Ege University
Istanbul Arel University
Building similarity graph...
Analyzing shared references across papers
Loading...
Yakar et al. (Mon,) studied this question.
www.synapsesocial.com/papers/68e5c971b6db64358755fb3e — DOI: https://doi.org/10.1080/20002297.2024.2388900